Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Villa

Showing results (111-120 of 149) with videos related to

Pageof 15
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|December 8, 2018
Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovirMauro Viganò, Alessandro Loglio, Sara Labanca, et al.
Gastroenterology|July 24, 2012
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosisErica Villa, Calogero Cammà, Marco Marietta, et al.
The Lancet. Gastroenterology & Hepatology|May 13, 2017
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational studySalvatore Petta, Marco Marzioni, Pierluigi Russo, et al.
Journal of Viral Hepatitis|November 14, 2018
Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysisSteven Flamm, David Mutimer, Armen Asatryan, et al.
Scientific Reports|January 26, 2019
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access programVincenza Calvaruso, Chiara Mazzarelli, Laura Milazzo, et al.
Gut|February 11, 2015
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective studyErica Villa, Rosina Critelli, Barbara Lei, et al.
Journal of Hepatology|September 9, 2017
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCVAimilia Karampatou, Xue Han, Loreta A Kondili, et al.
Annals of Hepatology|February 13, 2022
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: A long-term follow-up studyStefano Gitto, Paolo Magistri, Luca Marzi, et al.
Advances in Therapy|October 29, 2024
Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated CirrhosisMarkus Cornberg, Dietrich Hüppe, Christoph Sarrazin, et al.
Journal of Hepatology|April 4, 2020
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosisAngelo Sangiovanni, Eleonora Alimenti, Riccardo Gattai, et al.
Pageof 15

Showing results (111-120 of 149) with videos related to

Sort By:
Pageof 15
Liver International : Official Journal of the International Association for the Study of the Liver|December 8, 2018
Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovirMauro Viganò, Alessandro Loglio, Sara Labanca, et al.
Gastroenterology|July 24, 2012
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosisErica Villa, Calogero Cammà, Marco Marietta, et al.
The Lancet. Gastroenterology & Hepatology|May 13, 2017
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational studySalvatore Petta, Marco Marzioni, Pierluigi Russo, et al.
Journal of Viral Hepatitis|November 14, 2018
Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysisSteven Flamm, David Mutimer, Armen Asatryan, et al.
Scientific Reports|January 26, 2019
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access programVincenza Calvaruso, Chiara Mazzarelli, Laura Milazzo, et al.
Gut|February 11, 2015
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective studyErica Villa, Rosina Critelli, Barbara Lei, et al.
Journal of Hepatology|September 9, 2017
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCVAimilia Karampatou, Xue Han, Loreta A Kondili, et al.
Annals of Hepatology|February 13, 2022
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: A long-term follow-up studyStefano Gitto, Paolo Magistri, Luca Marzi, et al.
Advances in Therapy|October 29, 2024
Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated CirrhosisMarkus Cornberg, Dietrich Hüppe, Christoph Sarrazin, et al.
Journal of Hepatology|April 4, 2020
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosisAngelo Sangiovanni, Eleonora Alimenti, Riccardo Gattai, et al.
Pageof 15